September 29, 2025 FDA Expands Options for Pediatric Psoriasis, PsA The FDA has approved the first IL-23 inhibitor for pediatric patients with plaque psoriasis and psoriatic arthritis. Conexiant
September 25, 2025 Mediterranean Diet Cut Psoriasis Severity Over 16 Weeks Dietitian-guided Mediterranean diet increases adherence and improves patient-reported psoriasis measures. Conexiant
September 25, 2025 GLP-1 RAs Show Lower Risks in Psoriasis GLP-1 RAs use in psoriasis is associated with lower alcohol and substance abuse risks. Conexiant
September 18, 2025 Psoriasis Linked to Macular Degeneration Vision-threatening eye disease more common in psoriasis patients, but biologic therapy appears protective. Conexiant
April 30, 2024 Novel Gene Variants May Be Predisposing Factor for Generalized Pustular Psoriasis Researchers may have uncovered genetic factors linked to the development of generalized pustular psoriasis. Conexiant
June 12, 2024 FAc Implant Shows Sustained Improvement in Uveitis Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure. Conexiant
January 07, 2025 Patient Insights on HRQOL in Chronic GVHD Explore how cutaneous graft-versus-host disease impacts patients’ quality of life across physical, psychological, and social domains. Conexiant
November 27, 2024 Processed Foods Linked to Active Psoriasis: Study French researchers in JAMA Dermatology linked high ultraprocessed food consumption to increased rates of psoriasis, emphasizing the need for further investigation. Conexiant
May 28, 2025 Kennedy Proposes NIH Publishing Ban "We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt." Conexiant